New Ashfield unit to meet pharma’s challenges
pharmafile | February 4, 2014 | News story | Medical Communications | ashfield healthcare
Ashfield healthcare has created a new division to integrate its eight units into one business area offering in an effort to meet the challenge of pharma’s changing environment.
The new unit combines eight service areas under the Ashfield division umbrella and has integrated its sales, marketing and medical service offerings into one division.
The company says it has done this to meet the industry demand for greater flexibility, insight and innovation from service providers such as itself.
In a statement it said it is reacting to the new global healthcare environment that is ‘increasingly complex’ and characterised by an escalation in specialty products, greater regulatory control and reimbursement difficulties.
The company believes that by bringing together individual business brands, including: Ashfield In2Focus, Business Edge, Pharmexx, InforMed, Watermeadow Medical, Pharma Marketing Academy and Universal WorldEvents under the Ashfield brand “provides even more value to clients through a cross-functional business approach”.
This enables Ashfield to work in partnership with clients to ensure impact, effectiveness and efficiency.
Chris Corbin, managing director of Ashfield Commercial and Medical Services, said: “This transformation of our business allows us to deliver more for the industry, healthcare professionals and patients through our combined expertise and insight, whilst retaining the ingenuity and energy that our companies are known for.
“We have always put our clients and customers first and uniting these businesses in one division will help us address their challenges even more effectively.”
The firm added: “Through an integration of services and a collaborative culture, Ashfield Commercial and Medical Services is able to harness excellence across its areas of expertise, creating a synergy that delivers more than the sum of the parts, to accelerate their clients success.”
